Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs eBay Inc (EBAY) Price & Performance

Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs eBay Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.69 (market cap $20.01M), while eBay Inc trades at $102.89 (market cap $47.17B). The key difference: eBay Inc is far larger — about 2357.3× Citius Pharmaceuticals Inc's market cap, and eBay Inc pays a 1.17% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

CTXREBAY
Market Cap
$20.01M$47.17B
Sector
HealthConsumer Cyclical
52-Week High
$1.82$118.96
52-Week Low
$0.48$79.41
Enterprise Value
$16.23M$51.00B
Volume
5,186,418
Dividend Yield
1.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Citius Pharmaceuticals Inc

CTXR is trading at $0.7126, up 5.26% today, with strong technical momentum showing bullish moving average signals. The company shows significant revenue growth potential with LYMPHIR commercialization expanding, though currently operates at substantial losses with a -823% net income margin. Analyst sentiment remains overwhelmingly positive with 83% buy ratings, reflecting optimism about the oncology pipeline and recent commercial progress.

The investment case hinges on successful LYMPHIR commercialization offsetting current losses, with strong institutional support providing runway. Key risks include execution challenges in scaling operations and the capital-intensive nature of biopharmaceutical development. The stock presents high-risk, high-reward potential for investors comfortable with clinical-stage biotech volatility.

eBay Inc

EBAY trades at $107.71, down 3.81% on news that GameStop may abandon its $56 billion takeover bid in favor of a partnership. The stock shows bearish technical signals but maintains strong fundamentals with 18.57% net margins and consistent earnings beats. Recent Q2 results exceeded expectations with 14% GMV growth, though insider selling and takeover uncertainty create near-term pressure.

EBAY offers solid fundamentals with improving revenue guidance and attractive valuation multiples, but faces significant event risk from the potential GameStop deal collapse. The 11% upside to consensus price target suggests moderate bullish sentiment, though investors should monitor partnership developments and Q3 earnings for directional clarity.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR

About eBay Inc

eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.

Read more on EBAY